Core A: Administrative Core this Program Project is broadly focused on understanding the mechanisms by which inflammation modulates AD pathogenesis. An additional goal of this Program is to investigate how proteins recently identifled by Genome Wide Association Studies (GWAS) in Alzheimer disease (AD) contribute to endocytic dysfunction, which may trigger the inflammatory cascade, impair synaptic plasticity, disrupt the clearance of toxic proteins, and thereby increase AD risk. The Administrative Core oversees the activities of the Program Project and provides infrastructure support for Program Project investigators to facilitate the goals of the Program Project. The Administrative Core nurtures and promotes a multi-disciplinary, multi-investigator approach by coordinating and facilitating communication between the Cores and the Projects. The Core will organize bi-monthly meetings, a weekly seminar series that incorporates the themes of the current Program Project, and engage other AD-related programs at UCI and the Alzheimer's Disease Research Centers of Orange, Los Angeles and San Diego Counties to foster collaborations with Program Project investigators. The Core will annually assemble an External Advisory Committee to review research progress and provide guidance for the Program Project investigators. The Core will also monitor the Tissue, Peptide, and Genetics Core, as well as oversee availability and access to the UCI Alzheimer Disease Research Center (ADRC) database that encompasses clinical, neuropathological, neuroanatomical, biochemical, and genetic data from subjects (active and deceased) participating in the UCI ADRC (control and AD). Lastly, the Administrative Core coordinates the use of shared facilities, services, equipment and supplies by all Program Project investigators, assists in material transfer agreements, oversees animal use and IRB protocols and manages the financial budgets of the Cores and the projects.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
United States
Zip Code
Rice, Rachel A; Berchtold, Nicole C; Cotman, Carl W et al. (2014) Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiol Aging 35:1002-11
Elmore, Monica R P; Najafi, Allison R; Koike, Maya A et al. (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380-97
Berchtold, Nicole C; Sabbagh, Marwan N; Beach, Thomas G et al. (2014) Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol Aging 35:1961-72
Hatami, Asa; Albay 3rd, Ricardo; Monjazeb, Sanaz et al. (2014) Monoclonal antibodies against A?42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem 289:32131-43
Smith, Erica D; Prieto, G Aleph; Tong, Liqi et al. (2014) Rapamycin and interleukin-1? impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy. J Biol Chem 289:20615-29
Pensalfini, Anna; Albay 3rd, Ricardo; Rasool, Suhail et al. (2014) Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis 71:53-61
Passos, Giselle F; Medeiros, Rodrigo; Cheng, David et al. (2013) The bradykinin B1 receptor regulates A? deposition and neuroinflammation in Tg-SwDI mice. Am J Pathol 182:1740-9
Medeiros, Rodrigo; LaFerla, Frank M (2013) Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239:133-8
Benoit, Marie E; Hernandez, Michael X; Dinh, Minhan L et al. (2013) C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-* neurotoxicity. J Biol Chem 288:654-65
Fonseca, Maria I; McGuire, Susan O; Counts, Scott E et al. (2013) Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. J Neuroinflammation 10:25

Showing the most recent 10 out of 220 publications